Adolfo Gallego

Barcelona, CT 08041, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Immune Response and Risk of Decompensation following SARS-CoV-2 Infection in Outpatients with Advanced Chronic Liver Disease.

Immune Response and Risk of Decompensation following SARS-CoV-2 Infection in Outpatients with Advanced Chronic Liver Disease.

Journal: International journal of molecular sciences

Published: June 26, 2024

Survival and adverse events of elderly patients treated with sorafenib for hepatocellular carcinoma.

Survival and adverse events of elderly patients treated with sorafenib for hepatocellular carcinoma.

Journal: Frontiers in oncology

Published: December 05, 2021

Corrigendum to "Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules" [J Hepatol (2019) 874-884].

Corrigendum to "Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules" [J Hepatol (2019) 874-884].

Journal: Journal of hepatology

Published: December 15, 2020

Frailty in outpatients with cirrhosis: A prospective observational study.

Frailty in outpatients with cirrhosis: A prospective observational study.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: May 25, 2020

International and multicenter real-world study of sorafenib-treated patients with hepatocellular carcinoma under dialysis.

International and multicenter real-world study of sorafenib-treated patients with hepatocellular carcinoma under dialysis.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: December 28, 2019

Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension.

Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension.

Journal: Journal of hepatology

Published: December 02, 2019

Real-world evidence of the effectiveness of ombitasvir-paritaprevir/r ± dasabuvir ± ribavirin in patients monoinfected with chronic hepatitis C or coinfected with human immunodeficiency virus-1 in Spain.

Real-world evidence of the effectiveness of ombitasvir-paritaprevir/r ± dasabuvir ± ribavirin in patients monoinfected with chronic hepatitis C or coinfected with human immunodeficiency virus-1 in Spain.

Journal: PloS one

Published: July 24, 2019

Impact of sustained virological response with DAAs on gastroesophageal varices and Baveno criteria in HCV-cirrhotic patients.

Impact of sustained virological response with DAAs on gastroesophageal varices and Baveno criteria in HCV-cirrhotic patients.

Journal: Journal of gastroenterology

Published: May 23, 2019

Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules.

Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules.

Journal: Journal of hepatology

Published: July 02, 2018

Effectiveness and safety of elbasvir/grazoprevir therapy in patients with chronic HCV infection: Results from the Spanish HEPA-C real-world cohort.

Effectiveness and safety of elbasvir/grazoprevir therapy in patients with chronic HCV infection: Results from the Spanish HEPA-C real-world cohort.

Journal: Journal of viral hepatitis

Published: May 23, 2018

Potential drug-drug interactions of OMBITASVIR, PARITAPREVIR/ritonavir ± DASABUVIR ± ribavirin in clinical practice.

Potential drug-drug interactions of OMBITASVIR, PARITAPREVIR/ritonavir ± DASABUVIR ± ribavirin in clinical practice.

Journal: Journal of gastroenterology and hepatology

Published: June 08, 2017

Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated Cirrhosis.

Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated Cirrhosis.

Journal: Gastroenterology

Published: April 13, 2017

Showing 1-12 of 18

Last Updated: 09/26/2026